Floatz logo

PROPRANOLOL

Urethra Cancer

Emory UniversitySmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

15 Active assets in the Urethra Cancer cohort.

Asset / SponsorPhaseRating
Carboplatin
Jonsson Comprehensive Cancer Center
Phase 2BB
Vinflunine
Dr Anders Ullén
Phase 2BB
Sorafenib
Dr Anders Ullén
Phase 2B
CIS-DIAMMINEDICHLOROPLATINUM II
Jonsson Comprehensive Cancer Center
Phase 1/2B
Pembrolizumab
Emory University
Phase 2B

View all 29 →

Same molecule, other indications

PROPRANOLOL is also rated in:

migraine disorderDormant
BBB
Indicative ·
74 / 100
View asset →
esophageal varicesDormant
BBB
Indicative ·
74 / 100
View asset →
esophageal varices with bleedingDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →